USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Microbiome Technologies Energizing Pharma and Life Sciences
A New World of Microbiome Innovations
28-Jun-2017
Global
Technology Research
D7B3-01-00-00-00
HC02836-GL-TR_20310
$4,950.00
Special Price $3,712.50 save 25 %
Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witness across the microbiome industry parallels, the growth that took place across genomics. Some of the milestones that have occurred in the microbiome field are the application of next generation screening towards identifying and assessing microbial levels within the human gut. Using these microbial biomarkers, scientists are pushing the boundaries by identifying novel drug targets as well as probiotic or prebiotic products that could aid in balancing the microbial ecosystem within the human body.
1.1 Key Findings
1.2 Interest Across The “Microbiome” Rapidly Rising
1.3 The Past, Present & Future of Human Microbiomics
1.4 Microbiome Product Diversity And Segmentation
2.1 Technology Overview: Therapeutics
2.2 Technology Overview: Over-the-counter
2.3 Technology Overview: Diagnostic Products & Services
3.1 More than 50% of all Microbiome Research is Focused Towards the GI
3.2 Multiple Diseases Have Unmet Therapeutics Needs
3.3 Clostridium difficile Threat Increasing due to Increasing Antibiotic use
3.4 Inflammatory Bowel Disease Another Large Unmet Area of Urgent Need
3.5 Skin Disorders Have Found A New Age Therapeutic Solution
3.6 Lifestyle Disorders Could Also Be Controlled Through the Microbiome
3.7 Immune-Microbiome A New Avenue In Cancer Research
3.8 OTC Microbiome Products Have Numerous Consumer Target Segments
3.9 OTC Microbiome Products Promote A Balanced Micro-ecosystem
3.10 Documented Usage of Probiotics Across Human Health is Diverse
4.1 Largest Contribution Towards the Microbiome Product Landscape Comes from Probiotic Drugs
4.2 Microbiome Therapeutics are Developed to with a Strategic Technical Design Based Approach
4.3 OTC Microbiome Products – Key Segments
4.4 OTC Microbiome Products – Some Probiotics/Prebiotic Stakeholders
4.5 Current Microbiome Company Ecosystem Segmented by Technology Focus
4.6 Microbiome Stakeholders Mergers, Acquisitions & Partnerships Snapshot
5.1 Approach–Company Profile
5.2 Seres Health (Seres Therapeutics)
5.3 AvidBiotics
5.4 Rebiotix
5.5 Ritter Pharmaceutical
5.6 Vedanta Biosciences
5.7 C3 Jian
6.1 Regional Analysis of OTC Health Innovations
6.2 Regional Analysis of Diagnostic/Services Innovations
6.3 Technology Roadmap
7.1 Growth Opportunity 7: Microbiome
7.2 Major Growth Opportunities for Microbiome
7.3 Strategic Imperatives for Microbiome Technology Stakeholders
Legal Disclaimer
8.1 The Frost & Sullivan Story
8.2 Value Proposition: Future of Your Company & Career
8.3 Global Perspective
8.4 Industry Convergence
8.5 360º Research Perspective
8.6 Implementation Excellence
8.7 Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
04 Aug 2026 | Global | Market Research
Global Capnography Devices Market, Forecast to 2031
The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...
31 Jul 2026 | Global | Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...
30 Jul 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026
The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...
30 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.
The issue features advanced medical devices such as non-invasive bimoda...
24 Jul 2026 | Global | Frost Radar
Frost Radar™: Neuromodulation Devices, 2026
Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life, gaining momentum as a cost-efficient, long-term treatment for neurological and nerve-related disorders. The prevalence of neurological disorders and nerve inju...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Madhumitha Rangesa |
| Industries | Healthcare |
| WIP Number | D7B3-01-00-00-00 |
| Is Prebook | No |